VeriChip Corporation Sponsors the Alzheimer's Community Care 2007 Alzheimer's Educational Conference on June 7-8
Posted on: Wednesday, 6 June 2007, 12:00 CDT
VeriChip Corporation (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, announced today that it is the premier sponsor of the Alzheimer's Community Care 2007 Alzheimer's Educational Conference on June 7-8 in West Palm Beach, Florida. The conference, which is titled "Where there is help, there is hope," is presented by Alzheimer's Community Care (ACC) and The Alzheimer's Alliance, and will take place at the Palm Beach County Convention Center (650 Okeechobee Boulevard, West Palm Beach, Florida).
"In conjunction with VeriChip's two-year project with ACC in which 200 Alzheimer's patients and their caregivers are to receive the VeriMed™ RFID implantable microchip to provide emergency department staff easy access to those patients' identification and medical information, VeriChip is proud to sponsor this important event," said Scott R. Silverman, Chairman and CEO of VeriChip Corporation.
Alzheimer's disease is dramatically on the rise in the United States with 16-million new cases predicted by 2050.1 There can be a number of challenges associated with caring for these patients. One of the most concerning issues is having a centralized location for vital medical information accessible, regardless of the patient or caregiver's ability to communicate. The VeriMed Patient Identification System allows physicians in the emergency room to scan the patient's arm and immediately obtain his or her unique 16-digit identification number. The physician can then access the VeriMed database and obtain the patient's name and address, caregiver contact information, and current medical issues. At the exhibit, local physician, James Provo, MD, will perform the procedure on Alzheimer's patients and their caregivers.
"The VeriMed RFID implantable microchip can be an integral part of a comprehensive healthcare strategy, especially for those who suffer from chronic illnesses," said James C. Provo, MD. "In the ER, it is an absolute necessity to rapidly obtain emergency contacts, current prescriptions and medical history. All of that information helps us provide the appropriate care for our patients."
"By offering caregivers of Alzheimer's patients the VeriMed RFID implantable microchip, we are supporting the safety net which allows emergency medical professionals quick access to medical records for both the patient and the caregiver," said Mr. Silverman.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed Patient Identification System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.
VeriChip Corporation is majority-owned by Applied Digital Inc. (Nasdaq:ADSX), which also owns a majority position in Digital Angel Corporation (AMEX:DOC). For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at http://www.verichipcorp.com.
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
1 Alzheimer's Association
Source: Business Wire
Related Articles
- American Medical Directors Association Foundation to Initiate Study of VeriMed Patient Identification System
- VeriMed Patient Identification System Expands to Emergency Medical Responders
- VeriChip Passes Significant Milestone: Over 500 Hospitals Have Now Agreed to Adopt VeriMed Patient Identification System
- VeriChip Corporation Partners With Alzheimer's Community Care to Conduct Study of VeriMed Patient Identification System
- VeriChip Corporation Reports Year End Hospital and Physician Enrollments for Its VeriMed Patient Identification System
- VeriChip Corporation Adds 67 Hospitals/Emergency Rooms to Its VeriMed Patient Identification System Network at the Annual American College of Emergency Physicians Conference
- VeriChip's Patient Identification Microchips in Pilot Program
- VeriChip Corporation's VeriMed System for Patient Identification Selected By 13 New Hospitals; 97 Healthcare Facilities Have Now Agreed to Implement the VeriMed Patient Identification System
- VeriChip Corporation Expands Infrastructure Rollout of VeriMed Patient Identification System - 172 New Physicians Elect to Offer VeriMed ID System to Patients
- VeriChip Corporation Launches Online Resource Center for Its VeriMed Patient Identification Application
 |
 |
User Comments (0)
RSS Feeds